Intake of Long-Chain -3 Fatty Acids From Diet and Supplements in Relation to Mortality
Authors:
- Griffith A. BellGBGriffith A. Bell
- Elizabeth D. KantorEKElizabeth D. Kantor
- Johanna W. LampeJLJohanna W. Lampe
- Alan R. KristalAKAlan R. Kristal
- Susan R. HeckbertSHSusan R. Heckbert
- Emily WhiteEWEmily White
Open Access
- 3 February 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Epidemiology
- Vol. 179 (6) , 710-720
Abstract
Evidence from experimental studies suggests that the long-chain ω-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid have beneficial effects that may lead to reduced mortality from chronic diseases, but epidemiologic evidence is mixed. Our objective was to evaluate whether intake of long-chain ω-3 fatty acids from diet and supplements is associated with cause-specific and total mortality. Study participants (n = 70,495) were members of a cohort study (the Vitamins and Lifestyle Study) who were residents of Washington State aged 50–76 years at the start of the study (2000–2002). Participants were followed for mortality through 2006 (n = 3,051 deaths). Higher combined intake of eicosapentaenoic acid and docosahexaenoic acid from diet and supplements was associated with a decreased risk of total mortality (hazard ratio (HR) = 0.82, 95% confidence interval (CI): 0.73, 0.93) and mortality from cancer (HR = 0.77, 95% CI: 0.64, 0.92) but only a small reduction in risk of death from cardiovascular disease (HR = 0.87, 95% CI: 0.68, 1.10). These results suggest that intake of long-chain ω-3 fatty acids may reduce risk of total and cancer-specific mortality.Keywords
This publication has 40 references indexed in Scilit:
- Association Between Use of Specialty Dietary Supplements and C-Reactive Protein ConcentrationsAmerican Journal of Epidemiology, 2012
- The VITamin D and OmegA-3 TriaL (VITAL): Rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular diseaseContemporary Clinical Trials, 2012
- Omega-3 Fatty Acids and Cardiovascular DiseaseJACC, 2011
- Dealing With Dietary Measurement Error in Nutritional Cohort StudiesJNCI: Journal of the National Cancer Institute, 2011
- Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trialBMJ, 2010
- OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial InfarctionCirculation, 2010
- n–3 Fatty Acids and Cardiovascular Events after Myocardial InfarctionNew England Journal of Medicine, 2010
- Total mortality risk in relation to use of less-common dietary supplementsThe American Journal of Clinical Nutrition, 2010
- Use of Supplements of Multivitamins, Vitamin C, and Vitamin E in Relation to MortalityAmerican Journal of Epidemiology, 2009
- Fish consumption and risk of major chronic disease in menThe American Journal of Clinical Nutrition, 2008